Siemens Healthineers AG (SHL.DE)
| Previous close | 54.52 |
| Open | 54.90 |
| Bid | 54.42 x 0 |
| Ask | 54.46 x 0 |
| Day's range | 54.26 - 55.40 |
| 52-week range | 45.18 - 67.66 |
| Volume | |
| Avg. volume | 695,544 |
| Market cap | 61.678B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 34.80 |
| EPS (TTM) | 1.57 |
| Earnings date | 02 May 2022 - 06 May 2022 |
| Forward dividend & yield | 0.85 (1.61%) |
| Ex-dividend date | 16 Feb 2022 |
| 1y target est | 66.17 |
- Business Wire
Millions of Siemens Healthineers CLINITEST Rapid COVID-19 Antigen Self-Test Now Available in the U.S.
TARRYTOWN, N.Y., February 03, 2022--Siemens Healthineers announced today the CLINITEST® Rapid COVID-19 Antigen Self-Test1,2 is now available in the U.S. to self-test for the SARS-CoV-2 virus. The CLINITEST Rapid COVID-19 Antigen Self-Test uses a simple nasal swab to provide accurate COVID-19 test results (including for both the Omicron and Delta variants) in 15 minutes and comes in a five-test-per-box configuration—convenient for families, group, and/or serial testing needs. The test is approved
- Business Wire
Siemens Healthineers and Prisma Health Join Forces to Innovate Healthcare for South Carolina
GREENVILLE, S.C. & MALVERN, Pa., Jun 22, 2021--Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina. This Value Partnership is focused on healthcare innovation, workforce development, and improving health care for patients and communities served by Prisma Health. Through this relationship, Siemens Healthineers and Prisma Health will deploy the latest generation of medical technology at all Prisma Health
